Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates
Early in 2021, vaccines were rolled out against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), decreasing the number of infections, hospitalizations, and mortality rate. However, the emergence of new variants of concern (VOCs) in quick succession raised questions about the ability of the vaccines then available to counteract or protect against these variants, underscored by the rising number of […]
Continue reading »